Cancer & Biotech: Incyte’s Minjuvi (tafasitamab) won Japan approval for relapsed/refractory DLBCL in combination with lenalidomide, adding a new option for patients not eligible for transplant. Delaware Courts & IP: A Delaware judge invalidated patent claims in a bioscience dispute involving a French Novartis unit, clearing the way for radiopharmaceutical companies. Energy & Permitting: The Trump administration dropped its offshore wind permitting appeal, letting a First Circuit dismissal stand after Delaware and other states challenged the federal freeze. Grid & Data Centers: Federal regulators ordered major grid operators to fix rules and justify how they’ll handle new large loads like data centers, aiming to protect reliability while addressing ratepayer concerns. Healthcare Costs: ACA Marketplace deductibles jumped 37% for 2026, pushing many enrollees toward higher-deductible bronze plans. Delaware Policy & Housing/Tax: A Delaware bill would require intermediaries to collect short-term rental taxes for municipalities. Environment & Industry: DNREC opened a $29.7M environmental laboratory in Smyrna, replacing an older Dover facility to expand testing capacity. Local Business & Tourism: Delaware Tourism Office and 1440 Film Co. won a Telly Silver for “Back of House,” spotlighting the state’s food and beverage scene. EV Adoption: A Brookings scorecard ranks Delaware among the higher-performing states for EV readiness after federal incentive pullbacks.